FEB 06, 2014 1:00 PM PST

Perioperative analgesia

C.E. Credits: CE
Speaker
  • Professor, Anesthesiologist, University Complutense, Spain
    Biography
      Ignacio Alvarez Gomez de Segura teaches and practices anaesthesiology since 2005 at the Veterinary School of Complutense University of Madrid (Spain), where he graduated in 1986. He holds the ECVAA and ECLAM diplomate status. Previously he worked as head of the Animal Facility at the Experimental Surgery Department of of the (human) Hospital La Paz, also in Madrid (1988-2005).

    Abstract

    perioperative analgesia aims to minimize, or even eliminate pain during a surgical procedure. Currently this approach is rarely performed using a single analgesic drug and more commonly different types of analgesic drugs, such as opioids and non-steroidal anti-inflammatory drugs (NSAIDs), are combined. This approach is known as multimodal or polymodal analgesia and also includes other analgesic drugs and techniques such as alpha-2 adrenergic receptor agonists, ketamine, or loco-regional analgesic techniques. Another approach is the anticipation to perioperative pain by administering analgesic drugs before surgical injury occurs and thus preventing the animal suffering from pain. This approach is known as preemptive analgesia and may reduce pain not only intraoperatively but also postoperatively. Other relevant aspects include the expected pain intensity, which allows us to select the appropriate drugs or drug combinations. The duration of analgesic therapy should also conform to the expected duration of pain so as to provide the necessary coverage postoperatively. Fortunately, there are on the market analgesic formulations with an effect typically lasting 24 hours with some of them providing analgesia up to 4 days following a single drug administration. Despite these advances, a good postoperative analgesia can only be obtained with an appropriate pain assessment system that would allow changes to the analgesic regimen in order to limit or prevent pain effectively.


    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    FEB 19, 2020 11:00 AM PST
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    JUN 23, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    Loading Comments...
    Show Resources
    Attendees
    • See more